| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Tuesday - Mar 19, 2024 |
|||||||||
|
Core & Main
CNM
|
Q4 FY23 | $0.38 | $0.35 | $1.44B | $1.43B |
NYSE |
|||
Caleres
CAL
|
Q4 FY23 | $0.86 | $0.86 | $697.12M | $694.33M |
NYSE |
|||
|
HealthEquity
HQY
|
Q4 FY24 | $0.63 | $0.56 | $262.39M | $258.55M |
NASDAQ |
|||
|
Citi Trends
CTRN
|
Q4 FY23 | $0.53 | $0.80 | $215.18M | $216.32M |
NASDAQ |
|||
|
Smith Douglas Homes
SDHC
|
- | $0.43 | $0.40 | $217.32M | $207.42M |
NYSE |
|||
|
The Real Good Food
RGF
|
- | -$0.34 | -$0.05 | $52.62M | $65.11M |
NASDAQ |
|||
|
Mitek Systems
MITK
|
Q4 FY23 | $0.15 | $0.14 | $39.12M | $41.68M |
NASDAQ |
|||
|
Zeo Energy
ZEO
|
- | -$0.14 | - | $37.89M | - |
NASDAQ |
|||
|
Harrow Health
HROW
|
- | -$0.27 | -$0.05 | $36.36M | $37.86M |
NASDAQ |
|||
|
Ponce Financial Group
PDLB
|
- | $0.02 | - | $35.74M | - |
NASDAQ |
|||
|
DiaMedica Therapeutics
DMAC
|
- | -$0.14 | -$0.14 | $30.84M | - |
NASDAQ |
|||
|
Strawberry Fields REIT LLC
STRW
|
- | $0.11 | - | $25.48M | $25.50M |
AMEX |
|||
|
TeraWulf
WULF
|
Q4 FY23 | -$0.03 | -$0.02 | $23.29M | $24.16M |
NASDAQ |
|||
|
Oxford Square Capital
OXSQZ
|
- | -$0.12 | $0.15 | $12.08M | $13.20M |
NASDAQ |
|||
|
Scholar Rock Holding
SRRK
|
- | -$0.50 | -$0.49 | $11.66M | - |
NASDAQ |
|||
|
National Bankshares
NKSH
|
- | $0.71 | $0.71 | $10.73M | $11.20M |
NASDAQ |
|||
|
Coya Therapeutics
COYA
|
- | $0.15 | $0.26 | $6M | $7.50M |
NASDAQ |
|||
|
Synlogic
SYBX
|
- | -$1.71 | -$1.11 | $2.77M | $2.73M |
NASDAQ |
|||
|
Taysha Gene Therapies
TSHA
|
Q4 FY23 | $0.35 | -$0.09 | $3.60M | $2.65M |
NASDAQ |
|||
|
Tourmaline Bio
TRML
|
- | -$0.81 | -$0.75 | $2.28M | - |
NASDAQ |
|||
|
Precigen
PGEN
|
Q4 FY23 | -$0.09 | -$0.08 | $1.23M | $2.13M |
NASDAQ |
|||
|
Oblong
OBLG
|
- | -$2.93 | -$30.00 | $944K | $1.43M |
NASDAQ |
|||
|
Bridger Aerospace Group Holdings
BAER
|
Q4 FY23 | -$0.80 | - | $1.11M | - |
NASDAQ |
|||
|
Design Therapeutics
DSGN
|
Q4 FY23 | -$0.21 | -$0.32 | $838K | - |
NASDAQ |
|||
|
Adicet Bio
ACET
|
- | -$11.04 | -$11.52 | - | $620K |
NASDAQ |
|||
|
Tyra Biosciences
TYRA
|
- | -$0.53 | -$0.48 | $502K | - |
NASDAQ |
|||
|
Westwater Resources
WWR
|
- | $0.04 | - | $274K | - |
AMEX |
|||
|
Corvus Pharmaceuticals
CRVS
|
Q4 FY23 | -$0.14 | -$0.14 | $246K | - |
NASDAQ |
|||
|
Cyclacel Pharmaceuticals
CYCC
|
- | -$6.23 | -$6.35 | $31K | - |
NASDAQ |
|||
|
ImmunityBio
IBRX
|
- | -$0.19 | -$0.18 | $139K | $20K |
NASDAQ |
|||
|
Tempest Therapeutics
TPST
|
- | -$4.42 | -$4.94 | - | - |
NASDAQ |
|||
|
Lixte Biotechnology Holdings
LIXT
|
- | -$0.41 | - | - | - |
NASDAQ |
|||
|
Relmada Therapeutics
RLMD
|
Q4 FY23 | -$0.84 | -$0.88 | - | - |
NASDAQ |
|||
| Show 23 more companies | |||||||||
